Article | March 3, 2025

Enabling Subcutaneous Delivery For Improved Patient Compliance And Healthcare System Efficiencies

Source: Nanoform
Doctor Preparing Injection Site GettyImages-1379313214

Nanoform Biologics' new subcutaneous delivery platform promises to transform biologics administration. By overcoming key obstacles like volume constraints and protein clumping, their technology allows for highly concentrated, stable injections under the skin. This breakthrough could significantly improve patient access, adherence, and treatment effectiveness, offering a vital solution as the demand for biologics surges.

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Nanoform